A detailed history of Natixis transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Natixis holds 15,168 shares of DGX stock, worth $2.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,168
Previous 11,172 35.77%
Holding current value
$2.08 Million
Previous $1.53 Million 35.97%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$137.09 - $137.09 $547,811 - $547,811
3,996 Added 35.77%
15,168 $2.08 Million
Q2 2024

Aug 13, 2024

SELL
$125.91 - $144.34 $1.1 Million - $1.26 Million
-8,711 Reduced 43.81%
11,172 $1.53 Million
Q1 2024

May 13, 2024

SELL
$123.78 - $142.11 $2.11 Million - $2.42 Million
-17,043 Reduced 46.15%
19,883 $2.65 Million
Q4 2023

Feb 13, 2024

SELL
$120.62 - $141.12 $1.05 Million - $1.23 Million
-8,725 Reduced 19.11%
36,926 $5.09 Million
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $551,660 - $656,052
4,527 Added 11.01%
45,651 $5.56 Million
Q2 2023

Aug 11, 2023

SELL
$130.56 - $146.84 $35.5 Million - $39.9 Million
-271,624 Reduced 86.85%
41,124 $5.78 Million
Q1 2023

May 12, 2023

BUY
$131.53 - $155.76 $25.5 Million - $30.2 Million
193,719 Added 162.75%
312,748 $44.2 Million
Q4 2022

Feb 24, 2023

BUY
$123.31 - $157.26 $5.67 Million - $7.23 Million
45,973 Added 62.93%
119,029 $18.6 Million
Q4 2022

Feb 13, 2023

BUY
$123.31 - $157.26 $311,727 - $397,553
2,528 Added 3.58%
73,056 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $601,909 - $697,457
4,943 Added 7.54%
70,528 $8.66 Million
Q2 2022

Aug 12, 2022

SELL
$127.07 - $145.39 $25.6 Million - $29.2 Million
-201,180 Reduced 75.41%
65,585 $8.73 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $1.35 Million - $1.72 Million
10,442 Added 4.07%
266,765 $36.5 Million
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $28.6 Million - $35.3 Million
203,819 Added 388.2%
256,323 $44.3 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $6.98 Million - $8.3 Million
52,504 New
52,504 $7.63 Million
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $3.09 Million - $3.46 Million
-24,422 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $2.95 Million - $3.43 Million
-25,759 Reduced 51.33%
24,422 $3.13 Million
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $1.9 Million - $2.16 Million
16,846 Added 50.54%
50,181 $5.98 Million
Q3 2020

Nov 12, 2020

BUY
$107.05 - $130.01 $1.53 Million - $1.86 Million
14,291 Added 75.04%
33,335 $3.82 Million
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $1.4 Million - $2.33 Million
19,044 New
19,044 $2.17 Million
Q4 2019

Feb 14, 2020

SELL
$100.29 - $107.99 $14.3 Million - $15.4 Million
-143,041 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$97.85 - $107.42 $14 Million - $15.4 Million
143,041 New
143,041 $15.3 Million
Q2 2019

Aug 13, 2019

SELL
$85.18 - $101.94 $1.53 Million - $1.84 Million
-18,014 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $14.2 Million - $15.8 Million
-175,505 Reduced 90.69%
18,014 $1.6 Million
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $470,684 - $639,658
-5,902 Reduced 2.96%
193,519 $16.1 Million
Q3 2018

Nov 14, 2018

BUY
$105.42 - $114.99 $5.07 Million - $5.53 Million
48,116 Added 31.8%
199,421 $21.5 Million
Q2 2018

Aug 14, 2018

BUY
$97.35 - $113.14 $13 Million - $15.1 Million
133,040 Added 728.39%
151,305 $16.6 Million
Q1 2018

May 15, 2018

SELL
$96.42 - $107.88 $1.84 Million - $2.06 Million
-19,094 Reduced 51.11%
18,265 $1.82 Million
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $1.32 Million - $1.45 Million
14,482 Added 63.3%
37,359 $3.68 Million
Q3 2017

Nov 14, 2017

SELL
$91.96 - $108.35 $2.66 Million - $3.14 Million
-28,945 Reduced 55.85%
22,877 $2.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
51,822
51,822 $5.76 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.